(IN BRIEF) After nearly a decade of research, Beiersdorf has revealed a groundbreaking discovery in skincare: a patented active ingredient called NAHP, also known as GLYCOSTOP™, designed to counteract the skin’s glycation process induced by sugar consumption, which contributes to … Read the full press release
(IN BRIEF) Prudential plc, a prominent insurance company in Asia and Africa, has announced a significant investment of US$2.5 million through its community investment arm, Prudence Foundation, to tackle the effects of climate change on health and enhance climate resilience, … Read the full press release
Posted in Banks, Business, Environment, Financial, Healthcare, Industrial, Insurance, Investment, Management, News, Non Profit, United Kingdom
Tagged Climate & Health Resilience Fund, climate change impacts, Diana Guzman, Financial, investment, Kathy Baughman McLeod, Prudence Foundation, Prudential, sustainability
(IN BRIEF) A recent survey commissioned by Continental highlights German drivers’ perspectives on health checks and advanced driver assistance systems (ADAS). Almost two-thirds of respondents consider regular health checks a sensible means to assess fitness for driving, with significant generational … Read the full press release
(IN BRIEF) The Philips Museum in Eindhoven, Netherlands, is set to unveil its new exhibition, ‘brAInpower,’ on April 20th, focusing on artificial intelligence (AI) and its impact, particularly in healthcare. Through interactive elements, rare collection pieces, and informative videos, visitors … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Healthcare, Industrial, Investment, Management, Media, Netherlands, News, Science, Technology
Tagged brAInpower, Healthcare, Interactive AI Exhibition, Philips, Philips Museum, Shez Partovi
(IN BRIEF) An international research group, led by Professor Stefan Feuerriegel from LMU, is pioneering the application of causal machine learning (ML) in medical diagnostics and therapy. Published in Nature Medicine, their study asserts that causal ML has the potential … Read the full press release
(IN BRIEF) The University of Liverpool has secured £1.3m in funding to support the UK Government’s Fleming Fund Fellowship Programme, aimed at addressing antimicrobial resistance (AMR) in partner countries. Led by Professor Alison Holmes, the program will provide mentorship and … Read the full press release
Posted in Business, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, United Kingdom
Tagged antimicrobial resistance, Dr Derek Cocker, Dr Kat Stott, Dr Steve Aston, Fleming Fund Programme, Nigeria, partnership, Professor Alison Holmes, Sierra Leone, sustainability, University of Liverpool
(IN BRIEF) Sanofi’s experimental CD40L antibody, frexalimab, demonstrates encouraging results in a 48-week phase 2 study for relapsing multiple sclerosis (MS). Presented at the American Academy of Neurology Annual Meeting, the data reveals sustained reduction in disease activity and favorable … Read the full press release
Posted in Business, Education, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged CD40L antibody, Erik Wallström, Frexalimab, multiple sclerosis, Patrick Vermersch, safety, Sanofi
(IN BRIEF) Novartis revealed promising data from the ALITHIOS open-label extension study, highlighting the enduring effectiveness of Kesimpta® (ofatumumab) in treating relapsing multiple sclerosis (RMS) over a span of up to six years. The study, presented at the American Academy … Read the full press release
(IN BRIEF) AstraZeneca’s IMPACT CKD model predicts a significant increase in chronic kidney disease (CKD) across eight countries, with up to 16.5% of the population affected by 2032, including a substantial rise in advanced-stage cases. Presented at the 2024 ISN … Read the full press release
(IN BRIEF) Bosch and Randox Laboratories Ltd. have forged a strategic partnership aimed at transforming molecular diagnostics with a focus on the Vivalytic analysis platform. With an investment of 150 million euros in joint research, development, and distribution, the collaboration … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Ireland, Management, News, Pharma & Biotech, Science, Technology
Tagged Bosch, Dr. Peter Fitzgerald, Healthcare, Marc Meier, Molecular Diagnostics, partnership, Randox Labs, Stefan Hartung
(IN BRIEF) The European Bank for Reconstruction and Development (EBRD) has provided a €22 million loan to Ukrainian pharmaceutical giant Farmak Group to facilitate its strategic acquisition of a Polish pharmaceutical company and to upgrade its IT systems. Farmak, a … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Poland, Science, Technology, Ukraine, United Kingdom
Tagged acquisition, EBRD, expansion, Farmak, Frederic Lucenet, investment, partnership, Poland, sustainability, UKRAINE
(IN BRIEF) Royal Philips announces the final agreement on a consent decree for its subsidiary, Philips Respironics, with the US Department of Justice (DOJ) and the US Food and Drug Administration (FDA). The decree primarily focuses on Respironics’ US operations, … Read the full press release
Posted in Business, Electronics & Machinery, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Security & Safety, Technology
Tagged DOJ, FDA, Philips, Philips Respironics, Roy Jakobs, safety, Steve C. de Baca
(IN BRIEF) A recent study conducted by researchers from the Universities of Bristol and Bath, King’s College London, and University Medical Center Utrecht highlights the concerning prevalence of repeat antibiotic prescriptions for respiratory tract infections (RTIs) within the same episode … Read the full press release
Posted in Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Alastair Hay, Arief Lalmohamed, King’s College London, partnership, Repeat Antibiotic Prescriptions, Respiratory Tract Infections, sustainability, UK Primary Care, University Medical Center Utrecht, University of Bath, University of Bristol
(IN BRIEF) A study conducted at the University of Helsinki under the DyslexiaBaby project reveals that infants’ neural responses to speech sounds can predict their later development of language and literacy skills. Stronger neural responses in the left side of … Read the full press release
(IN BRIEF) A groundbreaking study led by researchers from the University of Exeter, the Wellcome Sanger Institute, and the University of Cambridge introduces a novel approach to genetic testing, potentially revolutionizing the diagnosis of rare developmental disorders in children. By … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Caroline Wright, Children with Rare Disorders, early diagnosis, Helen Firth, partnership, Professor Matthew Hurles, Single Genetic Test, sustainability, University of Cambridge, University of Exeter, Wellcome Sanger Institute
(IN BRIEF) WACKER’s mRNA competence center in Halle is gearing up to produce an active ingredient for combatting acute respiratory distress syndrome (ARDS) in collaboration with Pantherna Therapeutics. The center, equipped with four new production lines, will more than triple … Read the full press release
Posted in Business, Chemicals, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged ARDS Treatment, Dr. Guido Seidel, Dr. Jörg Kaufmann, mRNA Production, PAN004, Pantherna, partnership, sustainability, WACKER
(IN BRIEF) AstraZeneca announces positive outcomes from the ADRIATIC Phase III trial, revealing that its immunotherapy drug Imfinzi (durvalumab) demonstrated a significant improvement in overall survival (OS) and progression-free survival (PFS) among patients with limited-stage small cell lung cancer (LS-SCLC) … Read the full press release
(IN BRIEF) French medtech company Wandercraft secures €25 million financing from the European Investment Bank (EIB) to advance the development of their groundbreaking Personal Exoskeleton. This innovative device, the first self-balancing exoskeleton designed for daily use by individuals with severe … Read the full press release
Posted in Banks, Business, Economy, Electronics & Machinery, Environment, Financial, France, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, News, Technology
Tagged Ambroise Fayolle, Atalante X, EIB, France, Matthieu Masselin, partnership, Personal Exoskeleton Development, rehabilitation, sustainability, Wandercraft
(IN BRIEF) Basilea Pharmaceutica Ltd, a biopharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for ZEVTERA® (ceftobiprole medocaril sodium for injection). The approval covers its use in adult patients with Staphylococcus aureus bloodstream infections (bacteremia), … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Adesh Kaul, Basilea, David Veitch, Dr. Marc Engelhardt, FDA, Pediatric Use, safety, Severe Bacterial Infections, Thomas Holland, Vance G. Fowler, Zevtera®
(IN BRIEF) Unitaid has allocated over £6 million in new funding to the University of Liverpool-led LONGEVITY project, aimed at enhancing long-acting therapeutics for tuberculosis, malaria, and hepatitis C. Started in 2020, the project has achieved preclinical milestones for long-acting … Read the full press release
Posted in Business, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Non Profit, Science, Switzerland, Technology, United Kingdom
Tagged hepatitis C, Infectious Disease Therapeutics, LONGEVITY Project, malaria, partnership, Professor Andrew Owen, Professor Louise Kenny, Professor Steve Rannard, Professor Tariq Ali, Professor Wiebe Van Der Hoek, sustainability, Switzerland, tuberculosis, UNITAID, University of Liverpool
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?